There were 1,876 press releases posted in the last 24 hours and 316,499 in the last 365 days.

Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results

/EIN News/ -- CAMBRIDGE, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, August 9, 2016, at 5:00 p.m. ET to discuss a corporate update and results for the second quarter of 2016.

To access the call, please dial 877-809-6321 (domestic) or 615-247-0223 (international) and provide the passcode 56269948. A live webcast of the presentation will be available on the Investors & Media section of the Editas website at                                             

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The Company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients. 

Media Contact 
Dan Budwick

Pure Communications, Inc.

(973) 271-6085

Investor Contact
Jesse Baumgartner
Stern Investor Relations, Inc.
(212) 362-1200

Primary Logo